2 results
Approved WMOCompleted
Our study tries to identify the ideal sclerosant dosage for the ClariVein® system in order to occlude the GSV permanently. By choosing the lowest dose with the same anatomical success rate, we achieve a safe treatment which also gives us the…
Approved WMOCompleted
The aim of this postmarket study is to compare the safety and effectiveness of Coloplast Restorelle® transvaginal mesh products in the treatment of pelvic organ prolapse (POP) to traditional native tissue repair through 36 months of follow-up. This…